Q3 2021 Sartorius AG Earnings Call Transcript
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the 9 months 2021 results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.
Thank you very much, and good day, everybody. Welcome to our conference call on our 9 months results for 2021 for both the Sartorius Group as well as for the Sartorius Stedim Biotech Group. We would like to kick it off by taking you though the Sartorius AG, Sartorius Group's numbers first and then directly after that through the results for Sartorius Stedim Biotech, and then we open the line for Q&A.
Before I hand over to Rainer, our CFO, I would like to just highlight the most important results of the first 9 months in 2021. Both divisions continue to have very -- to show a very dynamic double-digit growth in both order intake as well sales revenue, pretty much as expected, I would say, in Q3 then in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
